Tech Company Financing Transactions
Augmedix Funding Round
Augmedix, based in San Francisco, secured $19 million in funding from DCM Ventures, McKesson Ventures and Redmile Group.
Transaction Overview
Company Name
Announced On
10/25/2019
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series B
Investors
Proceeds Purpose
The company will use this fresh funding to accelerate product development, including automation capabilities, and to strategically scale its technology-enabled service across health systems and private clinics nationwide.
Company Information
Company Status
Publicly-held
Industry
Software
Mailing Address
1161 Mission St. 210
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Website
Email Address
Overview
Augmedix is a documentation solution that saves physicians 15 hours a week. Remote scribes do all the work, doctors review and sign in 3 min!
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Ian Shakil
Chief Executive Officer
Manny Krakaris
Chief Financial Officer
Matteo Marchetta
Chief Operating Officer
Sandra Breber
Chief Technical Officer
Sriram Vaidyanathan
VP - Human Resources
Lia Horii
VP - Sales
Jonathan Hawkins
Browse more venture capital transactions:
Prev: 10/25/2019: DiligenceVault venture capital transaction
Next: 10/25/2019: Weave venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs